{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:2955",
      "entity_text" : "DDS",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02040",
      "entity_text" : "VSL#3",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In the case of the VSL # 3 product, Biagioli recently [XREF_BIBR] failed to confirm that the Italy-made VSL # 3 is comparable to the US-made VSL # 3 for its protective action at the level of TJ [XREF_BIBR - XREF_BIBR], in terms of reduction of colitis [XREF_BIBR - XREF_BIBR] and colonic inflammation [XREF_BIBR] in dextran sodium sulphate induced (DDS) treated mice and in Muc2 mucin deficient mice.",
  "reading_complete" : "2020-07-28T14:48:00Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:42:24Z",
  "trigger" : "induced",
  "evidence" : [ "VSL#3 is comparable to the US-made VSL#3 for its protective action at the level of TJ [ XREF_BIBR - XREF_BIBR ], in terms of reduction of colitis [ XREF_BIBR - XREF_BIBR ] and colonic inflammation [ XREF_BIBR ] in dextran sodium sulphate-induced (DDS" ],
  "pmc_id" : "6425067",
  "score" : 0
}